Biospectrum, Inc.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 4 name spellings.
1
Ending by 2030
Jan 2028
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Nov 7, 2027The maintenance fee for Callus lysate comprising high content of callus metabolite and preparation method thereof (US 11,975,095) comes due Nov 7, 2027. Unpaid by May 8, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 7 of 7
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,994,141 | Compositions comprising compounds of natural origin for damaged skin In force · From the USPTO record | In force | From the USPTO record | |
| US 9,730,872 | Method for improving skin conditions with veratric acid or acceptable salt thereof as an active ingredient In force · From the USPTO record | In force | From the USPTO record | |
| US 10,130,670 | Composition for treating or preventing inflammatory skin disease, comprising, as active ingredient, immature citrus fruit extract, or synephrine or salt thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 12,303,588 | Composition containing Cirsium japonicum extract as active ingredient for stimulating melanogenesis In force · From the USPTO record | In force | From the USPTO record | |
| US 11,975,095 | Callus lysate comprising high content of callus metabolite and preparation method thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 12,502,374 | Composition for preventing, alleviating, or treating inflammatory disease containing isookanin or salt thereof as active ingredient In force · From the USPTO record | In force | From the USPTO record | |
| US 12,409,200 | Composition for treating hair loss or promoting hair growth comprising milk thistle flower extract as an active ingredient In force · From the USPTO record | In force | From the USPTO record |
Also on record, not counted in the 7: 1 lapsed for an unpaid fee · 5 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
7 no status recorded